Intelligence Profile
Research Papers
Research Papers and Clinical Trials
The research on PT-141 (bremelanotide) is primarily focused on its use for treating sexual dysfunction, particularly in women. However, the available evidence summaries provide limited specific details about study methodologies and results.
Clinical Trial Evidence
Three completed clinical trials have evaluated bremelanotide for female sexual dysfunction:
Two Phase 3 trials (NCT02338960 and NCT02333071) specifically studied bremelanotide's efficacy and safety in premenopausal women with hypoactive sexual desire disorder (HSDD). Both trials have been completed, though specific sample sizes and detailed results are not provided in the available evidence.
One Phase 2 trial (NCT01382719) examined bremelanotide in premenopausal women with female sexual arousal disorder and/or HSDD. This trial is also completed.
Published Research
Recent publications have examined bremelanotide within broader therapeutic contexts:
A 2026 systematic review in Frontiers in Medicine analyzed clinical trial evidence for emerging pharmacological therapies for HSDD in women, including studies registered on ClinicalTrials.gov, though specific findings about bremelanotide are not detailed in the available evidence.
A Journal of Clinical Psychopharmacology review (2026) specifically questioned whether bremelanotide should be considered for treating sexual arousal and desire disorders in men, suggesting research interest in expanding its applications beyond women.
Additional papers have discussed bremelanotide as part of broader therapeutic peptide research, including its mechanisms in aesthetic, metabolic, and endocrine conditions, and its role in gerontology applications.
Limitations of Available Evidence
The evidence summaries provided do not include specific study designs, sample sizes, primary endpoints, or detailed efficacy and safety results from these trials and reviews. More comprehensive data would be needed to fully assess the clinical evidence for PT-141/bremelanotide.
This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider for personalized medical guidance.